Skip to main content
  1. Bartelt LA, Markmann AJ, Nelson B, Keys J, Root H, Henderson HI, Kuruc J, Baker C, Bhowmik DR, Hou YJ, Premkumar L, Cornaby C, Schmitz JL, Weiss S, Park Y, Baric R, de Silva AM, Lachiewicz A, Napravnik S, van Duin D, Margolis DM. Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study. mBio. 2022 Oct 26;13(5):e0175122. PMC9601237.
  2. Barton K, Ferguson JM, Deveson IW, Falcinelli SD, James KS, Kirchherr J, Ramirez C, Gay CL, Hammond JM, Bevear B, Carswell SL. HIVepsilon-seq—scalable characterization of intact persistent proviral HIV reservoirs in women. Journal of Virology. 2023 Nov 30;97(11):e00705-23.
  3. Boyce RM, Muhindo E, Baguma E, Muhindo R, Shem B, François R, Hawke S, Shook-Sa BE, Ntaro M, Nalusaji A, Nyehangane D et al. Permethrin-treated baby wraps for the prevention of malaria: results of a randomized controlled pilot study in rural Uganda. Malaria Journal. 2022 Feb 23;21(1):63.
  4. Boyce RM, Ndizeye R, Ngelese H, Baguma E, Shem B, Rubinstein RJ, Rockwell E, Lotspeich SC, Shook-Sa BE, Ntaro M, Nyehangane D, Wohl DA, Siedner MJ, Mulogo EM, 2023. “It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda.” PLOS Global Public Health, 3(3): e0001678. PMC10042348
  5. Boyce RM, Shook-Sa BE, Aiello AE. A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence. Clinical Infectious Diseases. 2021 Nov;73(9):e3124-e3126. DOI: 10.1093/cid/ciaa1868. PMC7799336.
  6. Breger, T.L., Westreich, D., Edmonds, A., Edwards, J.K., Zalla, L.C., Cole, S.R., Ramirez, C., Ofotokun, I., Kassaye, S.G., Brown, T.T. and Konkle-Parker, D., 2022. A new smoking cessation ‘cascade’ among women with or at risk for HIV infection. AIDS, 36(1), pp.107-116. PMC8819357
  7. Breskin A, Cole SR, Edwards JK, Brookmeyer R, Eron JJ, Adimora AA. Fusion designs and estimators for treatment effects. Statistics in Medicine. 2021 Jun 15;40(13):3124-37. PMC8237350
  8. Castonguay B, LeMasters K, Corsi C, Batty E, Krajewski T, Travis M, Waleed M, Oser C, Nowotny K, Brinkley-Rubinstein L, 2023. “Retention strategies in the first pre-exposure prophylaxis (PrEP) observational cohort among those on community supervision in the south: Lessons learned during the COVID-19 pandemic.” PLOS ONE, 18(4), e0283621. PMC10075476
  9. Cerami C, Popkin-Hall ZR, Rapp T, Tompkins K, Zhang H, Muller MS, Basham C, Whittelsey M, Chhetri SB, Smith J, Litel C, Lin KD, Churiwal M, Khan S, Rubinstein R, Claman F, Mollan K, Wohl D, Premkumar L, Powers KA, Juliano JJ, Lin FC, Lin JT. Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color. Clin Infect Dis. 2021 Aug 12:ciab701. doi: 10.1093/cid/ciab701. Epub ahead of print. PMC8436395.
  10. Ceriani C, Streeter GS, Lemu KJ, James KS, Ghofrani S, Allard B, Shook-Sa BE, Margolis DM, Archin NM. Defining stable reference genes in HIV latency reversal experiments. Journal of virology. 2021 May 10;95(11):10-128. PMC8139712
  11. Chi BH, Saidi F, Graybill LA, Phanga T, Mollan KR, Amico KR, Freeborn K, Rosenberg NE, Hill LM, Hamoonga T, Richardson B. A patient-centered, combination intervention to support adherence to HIV pre-exposure prophylaxis during pregnancy and breastfeeding: a randomized pilot study in Malawi. Journal of Acquired Immune Deficiency Syndromes. 2022 May 13:10-97.
  12. Chibwesha CJ, Mollan KR, Ford CE, Shibemba A, Saha PT, Lusaka M, Mbewe F, Allmon AG, Lungu R, Spiegel HM, Mweni E. A randomized trial of point-of-care early infant human immunodeficiency virus (HIV) diagnosis in Zambia. Clinical Infectious Diseases. 2022 Jul 15;75(2):260-8.
  13. Ciccone EJ, Zhu DR, Gunderson AK, Hawke S, Ajeen R, Lodge EK, Shook-Sa BE, Abernathy H, Garrett HE, King E, Alavian N, Reyes R, Taylor JL, Beatty C, Chung C, Mendoza CE, Weber DJ, Markmann AJ, Premkumar L, Juliano JJ, Boyce RM, Aiello AE, 2024. “Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.” Open Forum Infect Dis, 11(1):ofae009. doi: 10.1093/ofid/ofae009. PMC10826795
  14. Clutton GT, Weideman AM, Goonetilleke NP, Maurer T. An expanded population of CD8dim T cells with features of mitochondrial dysfunction and senescence is associated with persistent HIV-associated Kaposi’s sarcoma under ART. Frontiers in Cell and Developmental Biology. 2022 Sep 29;10:961021.
  15. Clutton GT, Weideman AM, Mischell MA, Kallon S, Conrad SZ, Shaw FR, Warren JA, Lin L, Kuruc JD, Xu Y, Gay CM. CD3 downregulation identifies high-avidity human CD8 T cells. Clinical and Experimental Immunology. 2024 Mar 1;215(3):279-90. PMC10876116
  16. Cole, S.R., Edwards, J.K., Breskin, A., Hudgens, M.G., 2021. Comparing Parametric, Nonparametric, and Semiparametric Estimators: The Weibull Trials. American Journal of Epidemiology, 190(8), pp.1643-1651. PMC8484780
  17. Cole SR, Edwards JK, Breskin A, Rosin S, Zivich PN, Shook-Sa BE, Hudgens MG, 2022. “Illustration of 2 Fusion Designs and Estimators.” American Journal of Epidemiology, 192(3):467-474. PMC10372880
  18. Cole SR, Edwards JK, Zivich PN, Shook-Sa BE, Hudgens MG, Stringer JS. Reducing bias in estimates of per protocol treatment effects: a secondary analysis of a randomized clinical trial. JAMA Network Open. 2023 Jul 3;6(7):e2325907-. PMC10372700
  19. Cole SR, Shook-Sa BE, Zivich PN, Edwards JK, Richardson DB, Hudgens MG, 2024. “Higher-order evidence.” European Journal of Epidemiology. 39(1):1-11. PMID: 38195955.
  20. Cole SR, Zivich PN, Edwards JK, Shook-Sa BE, Hudgens MG, 2023. “Sensitivity Analyses for Means or Proportions with Missing Outcome Data.” Epidemiology, 34(5): 645-651. PMC10524136
  21. Cole SR, Zivich PN, Edwards JK, Ross RK, Shook-Sa BE, Price JT, Stringer JS, 2023. “Missing Outcome Data in Epidemiologic Studies.” American Journal of Epidemiology, 192(1), pp. 6-10. PMID: 36222655. PMC10144620
  22. Conner MG, Vwalika B, Freeman BL, Sebastião YV, Mabula-Bwalya CM, Cole SR, Stringer EM, Kasaro MP, Stringer JSA, Price JT. Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia. AIDS. 2022, 36(14), pp. 2079-2081. PMC9624437
  23. Council O, Tyers L, Moeser M, Sondgeroth A, Spielvogel E, Richardson B, Doolabh D, Zhou S, Emery A, Archin N, Shook-Sa B, Margolis D, Karim SA, Pond SK, Garrett N, Abrahams M, Joseph S, Williamson C, Swanstrom R. “The Persistent Pool of HIV-1-infected Cells is Formed Episodically During Untreated Infection.” Journal of Virology. Accepted.
  24. Curtis AD, Saha PT, Dennis M, Berendam SJ, Ramasubramanian P, Cross KA, Alam SM, Ferrari G, Kozlowski PA, Fouda GG, Hudgens MG, Van Rompay KKA, Pollara J, Permar SR, De Paris K. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection. mSphere. 2021 Oct 14;7(1):e00839-21. PMCID: PMC8865927
  25. Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, Van Duin D, Wohl DA, Gebo KA, Moore RD, Althoff KN, Poteat T, Gill MJ et al. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005–2015. AIDS. 2021 Jul 1;35(8):1229-39. PMC8172437
  26. Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, Van Duin D, Wohl DA, Hogan BC, Althoff KN, Gebo KA, Moore RD, Silverberg MJ. Current and past immunodeficiency are associated with higher hospitalization rates among persons on virologically suppressive antiretroviral therapy for up to 11 years. The Journal of Infectious Diseases. 2021 Aug 15;224(4):657-66.
  27. DeMonte, J., McCumber, M., Slye, N., Amico, K.R., Arnold, E.M., Comulada, W.S., Rezvan, P.H., Hightow-Weidman, L.B., Muessig, K.E., Nichols, S.L. Nielsen-Saines, K., Sanchez TH, Shook-Sa BE, Swendeman D, Valencia RK, Hudgens MG. 2023. “Adolescents Living With or at Risk for HIV: A Pooled Descriptive Analysis of Studies From the Adolescent Medicine Trials Network for HIV/AIDS Interventions.” Journal of Adolescent Health, 72(5): 712-721. PMC10121857
  28. Devanathan AS, Poliseno AJ, White NR, Schauer AP, Sykes C, Weideman AMK, Kilpatrick KW, Hudgens MG, Gay CL, Rosen EP, Dumond JB, Kashuba ADM, Cottrell ML. A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation. JAIDS J Acquir Immune Defic Syndr. November 21, 2024.
  29. Diepstra KL, Barr L, Palm D, Hogg E, Mollan KR, Henley L, Stover AM, Simoni JM, Sugarman J, Brown B, Sauceda JA et al. Participant perspectives and experiences entering an intensively monitored antiretroviral pause: results from the AIDS clinical trials group A5345 biomarker study. AIDS Research and Human Retroviruses. 2021 Jun 1;37(6):489-501. PMC8213012
  30. Edmonds A, Breskin A, Cole SR, Westreich D, Ramirez C, Cocohoba J, Wingood G, Cohen MH, Golub ET, Kassaye SG, Metsch LR. Poverty, deprivation, and mortality risk among women with HIV in the United States. Epidemiology 32, no. 6 (2021): 877-885. PMC8478815
  31. Edwards JK, Breger TL, Cole SR, Zivich PN, Shook-Sa BE, Sadinski LM, Westreich D. Edmonds A, Ramirez C, Ofotokun I, Kassaye S, Brown T, Konkle-Parker D, Stosor V, Bolan R, Krier S, Jones DL, D’Souza G, Cohen M, Tien P, Taylor T, Anastos K, Drummond MB, Floris-Moore M. “Right censoring and mortality in the Multicenter AIDS Cohort Study and Women’s Interagency HIV Study.” Epidemiology. Accepted.
  32. Edwards JK, Cole SR, Breger TL, Rudolph JE, Filiatreau LM, Buchacz K, Humes E, Rebeiro PF, D’Souza G, Gill MJ, Silverberg MJ. Mortality among persons entering HIV care compared with the general US population: an observational study. Annals of Internal Medicine. 2021 Sep;174(9):1197-206.
  33. Edwards JK, Cole SR, Breger TL, Filiatreau LM, Zalla L, Mulholland GE, Horberg MA, Silverberg MJ, John Gill M, Rebeiro PF, Thorne JE. Five-year mortality for adults entering human immunodeficiency virus care under universal early treatment compared with the general US population. Clinical Infectious Diseases. 2022 Sep 1;75(5):867-74.
  34. Edwards JK, Cole SR, Shook-Sa BE, Zivich PN, Zhang N, Lesko CR, 2023. “When Does Differential Outcome Misclassification Matter for Estimating Prevalence?” Epidemiology, 34(2):192-200. PMC10237297
  35. Edwards JK, Cole SR, Zivich PN, Hudgens MG, Breger TL, Shook-Sa BE (2024). “Semiparametric g-computation for survival outcomes with time-fixed exposures: an illustration.” Annals of Epidemiology. 96: 24-31. PMC11283356
  36. Falcinelli, S.D., Kilpatrick, K.W., Read, J., Murtagh, R., Allard, B., Ghofrani, S., Kirchherr, J., James, K.S., Stuelke, E., Baker, C. and Kuruc, J.D., Eron JJ, Hudgens MG, Gay CL, Margolis DM, Archin NM. Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of individuals receiving antiretroviral therapy. The Journal of Infectious Diseases. 2021 Jul 1;224(1):92-100. PMC8253129
  37. Fischer WA, Eron Jr JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Science Translational Medicine. 2021 Dec 23;14(628):eabl7430.
  38. Gao, X, MG Hudgens, F Zou. “Case-Cohort Studies with Time-Dependent Covariates and Interval-Censored Outcome.” In Emerging Topics in Modeling Interval-Censored Survival Data, pp. 221-234. Springer International Publishing, 2022
  39. Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Science Immunology. 2021 Jun 15;6(60):eabj3684.
  40. Golin CE, Rosen EP, Ferguson EG, Perry NR, Poliseno AJ, Munson AJ, Davis A, Hill LM, Keys J, White NR, Farel CE, Kashuba A. Feasibility, Acceptability and Appropriateness of MedViewer: A Novel Hair-Based Antiretroviral Real-Time Clinical Monitoring Tool Providing Adherence Feedback to Patients and Their Providers. AIDS Behavior. 2023 Dec;27(12):3886-3904. Epub 2023 Jul 26. PMID: 37493932.
  41. Graybill LA, Chi BH, Hamoonga TE, Kasaro M, Hodges JN, Richardson BD, Bissram JS, Saidi F, Mollan KR, Freeborn K, Rosenberg NE. Predictors of maternal HIV acquisition during pregnancy and lactation in sub-Saharan Africa: A systematic review and narrative synthesis. PloS One. 2024 Dec 3;19(12):e0314747.
  42. Graybill LA, McKay CN, Wang J, Sam-Agudu NA, Yotebieng M, Saidi F, Bekker LG, Shook-Sa BE, Chi BH, Rosenberg NE. “Characterizing populations prioritized for PrEP in 19 African countries: A review of national guidance.” Journal of the International AIDS Society. Accepted.
  43. Ha TV, Hoffman IF, Miller WC, Mollan KR, Lancaster KE, Richardson P, Zeziulin O, Djoerban Z, Sripaipan T, Chu VA, Guo X et al. Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: Results from HPTN 074. Journal of Substance Use. 2022 Nov 2;27(6):648-57.
  44. Harper GW, Cherenack EM, Slye N, Jadwin-Cakmak L, Hudgens M, 2023. “Pilot Trial of a Critical Consciousness-Based Intervention for Black Young Gay and Bisexual Men Living with HIV: Mobilizing Our Voices for Empowerment (MOVE).” J Racial Ethn Health Disparities, 10(1):64-82. PMC9296697
  45. Jetsupphasuk M, Hudgens MG, Lu H, Cole SR, Edwards JK, Adimora AA, Althoff KN, Silverberg MJ, Rebeiro PF, Lima VD, Marconi VC. Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. American Journal of Epidemiology. 2023 Aug;192(8):1341-9.
  46. Kandiyil VV, Curtis AD, Cross K, Van Rompay KK, Pollara J, Fox C, Tomai M, Hanke T, Fouda G, Hudgens M, Permar SR. Early post-vaccination gene signatures correlate with the magnitude and function of vaccine-induced HIV envelope-specific plasma antibodies in infant rhesus macaques. The Journal of Immunology. 2022 May 1;208(1_Supplement):126-40.
  47. King ER, Garrett HE, Abernathy H, Cassidy CA, Cabell CR, Shook-Sa BE, Juliano JJ, Boyce RM, Aiello AE, Ciccone EJ, 2023. “Comparison of capillary blood self-collection using the Tasso-SST device with venous phlebotomy for anti-SARS-CoV-2 antibody measurement.” J Immunol Methods, 520:113523. doi: 10.1016/j.jim.2023.113523. PMC10528948
  48. Knittel AK, Rudolph JE, Shook-Sa BE, Edmonds A, Ramirez C, Cohen M, Taylor T, Adedimeji A, Michel KG, Milam J, Cohen J. Self-Reported Sexually Transmitted Infections After Incarceration in Women with or at Risk for HIV in the United States, 2007–2017. Journal of Women’s Health. 2021a Dec 30. PMID: 34967695
  49. Knittel, A.K., Shook-Sa, B.E., Rudolph, J.E., Edmonds, A., Ramirez, C., Cohen, M.H., Adedimeji, A., Taylor, T.N., Michel, K.G., Milam, J. and Cohen, J., 2021. Incidence and Prevalence of Incarceration in a Longitudinal Cohort of Women at Risk for Human Immunodeficiency Virus in the United States, 2007–2017. Journal of Women’s Health, 30(5), pp.694-704. PMC8112715
  50. Krajewski T, LeMasters KH, Oser CB, Brinkley-Rubinstein L. Perceived versus actual HIV risk among PrEP indicated persons with criminal legal involvement. AIDS care. 2024 Nov 1;36(11):1647-56.
  51. Kumwenda A, Weideman AM, Graybill LA, Dinwiddie MK, Freeborn K, Lusaka MM, Lungu R, Mutale W, Rosenberg NE, Kasaro M, Mollan KR. Two strategies for partner notification and partner HIV self-testing reveal no evident predictors of male partner HIV testing in antenatal settings: A secondary analysis. International Journal of STD & AIDS. 2023 Dec;34(14):1004-11.
  52. Lancaster KE, Mollan KR, Hanscom BS, Shook-Sa BE, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Go VF, Dvoriak S, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Nhan DT, Burns DN, Miller WC, Hoffman IF. Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074. Open Forum Infect Dis. 2021 May 29;8(8):ofab281. doi: 10.1093/ofid/ofab281. PMC8391093.
  53. Lauckner C, Krajewski T, Mollan K, Nowotny KM, McLouth CJ, Oser CB, Brinkley-Rubinstein L. Associations between sexual minority status, hazardous drinking, and discrimination experiences among criminal legal-involved adults in the Southern PrEP Cohort (SPECS) study. Substance Use & Misuse. 2024 Oct 14;59(12):1751-7.
  54. LeMasters K, Benson A, Corsi C, Krajewski T, Seide K, Brinkley-Rubinstein L, Nowotny K, 2023. “Collateral consequences of COVID-19 for people on probation and parole.” Health & Justice, 11(1):18. doi: 10.1186/s40352-023-00221-0. PMC10060932
  55. LeMasters K, Krajewski T, Dong K, Brinkley-Rubinstein L, 2024. “Documenting competing needs to well-being among those on community supervision in the South.” Journal of Correctional Health Care, 30(1), 14–21. PMID: 38150566
  56. LeMasters K, Krajewski T, Nowotny K, Oser C, Mollan K, Brinkley-Rubinstein L. Context specific HIV risk: evidence from screening into the southern pre-exposure prophylaxis study (SPECS). AIDS Care. 2023 Apr 3;35(4):474-9.
  57. LeMasters K, Oser C, Cowell M, Mollan K, Nowotny K, Brinkley-Rubinstein L. Longitudinal pre-exposure prophylaxis (PrEP) acceptability, initiation and adherence among criminal justice-involved adults in the USA: the Southern PrEP Cohort Study (SPECS) protocol. BMJ Open. 2021 Jul 1;11(7):e047340.
  58. Li, F, AL Buchanan, SR Cole. Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials. Journal of the Royal Statistical Society: Series C, Applied Statistics. 2022 Jun;71(3):669-697. PMC9367209
  59. Li, L., Lee, C., Cruz, D.F., Krovi, S.A., Hudgens, M.G., Cottrell, M.L., Johnson, L.M., 2022. Reservoir-Style Polymeric Drug Delivery Systems: Empirical and Predictive Models for Implant Design. Pharmaceuticals, 15(10), p.1226. PMC9610229
  60. Li X, May S, Trumble IM, Archin NM, Hudgens MG. Paired serial limiting dilution assays. Statistics in Medicine. 2022 Oct 30;41(24):4809-21.
  61. Lin JT, Mollan KR, Cerami C. The Consequences of Isolating at Home. Clin Infect Dis. 2021 Nov 2;73(9):e2823. doi: 10.1093/cid/ciaa1476. PMID: 32986803.
  62. Lindsey, J.C., Hudgens, M., Gaur, A.H., Horvath, K.J., Dallas, R., Heckman, B., Johnson, M.M. and Amico, K.R., 2023. “Electronic dose monitoring device patterns in youth living with HIV enrolled in an adherence intervention clinical trial.” Journal of Acquired Immune Deficiency Syndromes, 92(3):p 231-241. DOI: 10.1097/QAI.0000000000003126. PMC9928806
  63. Lotspeich SC, Richardson BD, Baldoni PL, Enders KP, Hudgens MG, 2024. “Quantifying the HIV reservoir with dilution assays and deep viral sequencing.” Biometrics, 80(1):ujad018. PMC10873562
  64. Lu H, Cole SR, Westreich D, Hudgens MG, Adimora AA, Althoff KN, Silverberg MJ, Buchacz K, Li J, Edwards JK, Rebeiro PF. Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy. AIDS. 2022 Feb 1;36(2):277-86.
  65. Lu H, Cole SR, Westreich D, Hudgens MG, Adimora AA, Althoff KN, Silverberg MJ, Buchacz K, Li J, Edwards JK, Rebeiro PF. Clinical effectiveness of integrase strand transfer inhibitor–based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada. Clinical Infectious Diseases. 2021 Oct 1;73(7):e1408-14.
  66. McKellar MS, Keys JR, Filiatreau LM, McGee KS, Kuruc JD, Ferrari G, Margolis DM, Eron JJ, Hicks CB, Gay CL. Rapid viral suppression using integrase inhibitors during acute HIV-1 infection. J Antimicrobial Chemotherapy. 2024 Nov 6:dkae391. PMID: 39504491.
  67. McNeil, C.J., Lee, J.S., Cole, S.R., Patel, S.A., Martin, J., Mathews, W.C., Moore, R.D., Mayer, K.H., Eron, J.J., Saag, M.S. and Kitahata, M.M., 2022. Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk? AIDS, 36(5), pp.657-664. PMID: 34923519
  68. Milligan EC, Olstad K, Williams CA, Mallory M, Cano P, Cross KA, Munt JE, Garrido C, Lindesmith L, Watanabe J, Usachenko JL et al. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later. Science Translational Medicine. 2022 Dec 1;15(685):eadd6383.
  69. Mollan KR, Pence BW, Xu S, Edwards JK, Mathews WC, O’Cleirigh C, Crane HM, Eaton EF, Collier AC, Weideman AM, Westreich D. Transportability from randomized trials to clinical care: on initial HIV treatment with efavirenz and suicidal thoughts or behaviors. American Journal of Epidemiology. 2021 Oct;190(10):2075-84.
  70. Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL. Infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in symptomatic coronavirus disease 2019 (COVID-19) outpatients: host, disease, and viral correlates. Clinical Infectious Diseases. 2022 Jul 1;75(1):e1028-36.
  71. Mutale W, Freeborn K, Graybill LA, Lusaka MM, Mollan KR, Mweemba O, Kasaro M, Lungu R, Kumwenda A, Saidi F, Powers KA. Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials. The Lancet Global Health. 2021 Dec 1;9(12):e1719-29.
  72. Nelson, A.N., Dennis M, Mangold JF, Li K, Saha PT, Cronin K, Cross KA, Kumar A, Mangan RJ, Shaw GM, Bar KJ, Haynes B, Moody AM, Munir Alam S, Pollara J, Hudgens MG, Van Rompay KKA, De Paris K, Permar SR. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1. NPJ Vaccines. 2022 Jul 30;7(1):87. PMC9338948
  73. Nelson AN, Shen X, Vekatayogi S, Zhang S, Ozorowski G, Dennis M, Sewall LM, Milligan E, Davis D, Cross KA, Chen Y, et al. Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques. Science Immunology. 2024 Aug 30;9(98):eadm7097.
  74. Peterson JJ, Lewis CA, Burgos SD, Manickam A, Xu Y, Rowley AA, Clutton G, Richardson B, Zou F, Simon JM, Margolis DM. A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells. Cell Chemical Biology. 2023 Dec 21;30(12):1617-33.
  75. Pokaprakarn, T., Prieto, J.C., Price, J.T., Kasaro, M.P., Sindano, N., Shah, H.R., Peterson, M., Akapelwa, M.M., Kapilya, F.M., Sebastião, Y.V., Goodnight, W., Stringer EM, Freeman BL, Montoya LM, Chi BH, Rouse DJ, Cole SR, Vwalika B, Kosorok MR, and Stringer JSA. 2022. AI estimation of gestational age from blind ultrasound sweeps in low-resource settings. NEJM Evidence, 1(5), p.EVIDoa2100058, doi: 10.1056/EVIDoa2100058. PMC9980216
  76. Poliseno A, Ferguson E, Perry R, Munson A, Davis A, Hill L, Keys J, White N, Farel C, Gay C, Golin C. Establishing novel antiretroviral imaging for hair to elucidate nonadherence: protocol for a single-arm cross-sectional study. JMIR Research Protocols. 2023 Apr 21;12(1):e41188.
  77. Powers KA, Mutale W, Rosenberg NE, Graybill LA, Mollan KR, Freeborn K, Saidi F, Maman S, Mulenga PL, Jahn A, Nyirenda RK. Combination HIV prevention during pregnancy and the post‐partum period in Malawi and Zambia: a mathematical modelling analysis. Journal of the International AIDS Society. 2023 Jul;26(7):e26128.
  78. Price JT, Sebastião YV, Vwalika B, Cole SR, Mbewe FM, Phiri WM, Freeman BL, Kasaro MP, Peterson M, Rouse DJ, Stringer EM. Risk of adverse birth outcomes in two cohorts of pregnant women with HIV in Zambia. Epidemiology. 2022 May 1;33(3):422-30.
  79. Price JT, Vwalika B, Edwards JK, Cole SR, Kasaro MP, Rittenhouse KJ, Kumwenda A, Lubeya MK, Stringer JS. Maternal HIV Infection and Spontaneous Versus Provider-Initiated Preterm Birth in an Urban Zambian Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2021 Jun 1;87(2):860-8. PMC8131221
  80. Price JT, Vwalika B, Freeman BL, Cole SR, Saha PT, Mbewe FM, Phiri WM, Peterson M, Muyangwa D, Sindano N, Mwape H, et al. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial. The Lancet HIV. 2021 Oct 1;8(10):e605-13.
  81. Rittenhouse KJ, Mwape H, Nelson JA, Mwale J, Chipili G, Price JT, Hudgens M, Stringer EM, De Paris K, Vwalika B, Stringer JS. Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation. AIDS. 2021 Mar 15;35(4):555-65. PMC7944942
  82. Rosenberg, NE, Shook-Sa BE, Liu M, Stranix-Chibanda L, Yotebieng M, Sam-Agudu NA, Hudgens MG, …, BH Chi, 2023 “Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data.” The Lancet HIV, 10(3): E175-E185. PMC10126805
  83. Rosenberg NE, Shook-Sa BE, Young AM, Zou Y, Stranix-Chibanda L, Yotebieng M, Sam-Agudu NA, Phiri SJ, Mutale W, Bekker LG, Charurat ME, et al. An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled analysis across 15 nationally representative surveys. Clinical Infectious Diseases. 2024 In press.
  84. Rosenberg NE, Tembo TA, Simon KR, Mollan K, Rutstein SE, Mwapasa V, Masiano S, Huffstetler HE, Go V, Kim MH. Development of a Blended Learning Approach to Delivering HIV-Assisted Contact Tracing in Malawi: Applied Theory and Formative Research. JMIR Formative Research. 2022 Apr 19;6(4):e32899 PMC9066333
  85. Rosin SP, Shook-Sa BE, Cole SR, Hudgens MG, 2023. “Estimating SARS-CoV-2 seroprevalence.” Journal of the Royal Statistical Society Series A, Statistics in Society, 186(4):834-851. PMC10746549.
  86. Rubinstein, R.J., Mei, W., Cassidy, C.A., Streeter, G., Basham, C., Cerami, C., Lin, F.C., Lin, J.T. and Mollan, K.R., 2023. Transmission prevention behaviors in US households with SARS-CoV-2 cases in 2020. Frontiers in Epidemiology, 3, p.1160214.
  87. Sadinski, L.M., Westreich, D., Edmonds, A., Breger, T.L., Cole, S.R., Ramirez, C., Brown, T.T., Ofotokun, I., Konkle-Parker, D., Kassaye, S. and Jones, D.L., 2023. “Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States.” AIDS, 37(4), pp.679-688. PMC9974900
  88. Saidi F, Mutale W, Freeborn K, Rosenberg NE, Graybill LA, Maman S, Amico KR, Mollan KR, Phanga T, Milala B, Hill LM. Combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding: protocol for a pair of pilot randomised trials. BMJ Open. 2021 Jun 1;11(6):e046032.
  89. Saidi F, Phanga T, Graybill LA, Mollan KR, Hill LM, Sibande W, Msowoya G, Thom A, Rosenberg NE, Freeborn K, Amico KR. Acceptability of a combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding in Malawi. AIDS and Behavior. 2023 Dec;27(12):4022-32.
  90. Sanusi, B., Cai, J. and Hudgens, M.G., 2023. Nonparametric estimation of marked survival data in the presence of dependent censoring. Statistics in Medicine, 42(12), pp.1995-2008.
  91. Sanz M, Weideman AM, Ward AR, Clohosey ML, Garcia-Recio S, Selitsky SR, Mann BT, Iannone MA, Whitworth CP, Chitrakar A, Garrido C et al. Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1. Frontiers in Immunology. 2023 Sep 6;14:1219250.
  92. Shook-Sa BE, Hudgens MG, Kavee AL, Rosen DL (2022). “Estimating the Number of Persons with HIV in Jails via Web Scraping and Record Linkage.” Journal of the Royal Statistical Society, Series A, 185(S2), S270-S287. PMC9970294
  93. Shook-Sa BE, Hudgens MG, Knittel AK, Edmonds A, Ramirez C, Cole SR, Cohen M, Adedimeji A, Taylor T, Michel KG, Milam J, Cohen J, Donohue J, Foster A, Fischl M, Long D, Adimora AA. “Exposure effects on count outcomes with observational data, with application to incarcerated women.” Annals of Applied Statistics. 18(3): 2147-2165. PMC11526847
  94. Shook-Sa BE, Zivich PN, Rosin S, Edwards JK, Adimora AA, Hudgens MG, Cole SR, 2023. “Data fusion for treatment comparisons: single versus multi-span bridging.” Statistics in Medicine. 1-23. doi: 10.1002/sim.9989. PMC10843571
  95. Smith, J.S., Backes, D.M., Hudgens, M.G., Mei, W., Chakraborty, H., Rohner, E., Moses, S., Agot, K., Meijer, C.J. and Bailey, R.C., 2021. Male Circumcision Reduces Penile HPV Incidence and Persistence: A Randomized Controlled Trial in Kenya. Cancer Epidemiology and Prevention Biomarkers, 30(6), pp.1139-1148. PMC8172477
  96. Sponaugle A, Weideman AMK, Ranek J, Atassi G, Kuruc J, Adimora AA, Archin NM, Gay C, Kuritzkes DR, Margolis DM, Vincent BG, Stanley N, Hudgens MG, Eron JJ, Goonetilleke N, 2023. “Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV.” Cell Rep Med, 4(11):101268. PMC10694675
  97. Tembo TA, Mollan K, Simon K, Rutstein S, Chitani MJ, Saha PT, Mbeya-Munkhondya T, Jean-Baptiste M, Meek C, Mwapasa V, Go V. Does a blended learning implementation package enhance HIV index case testing in Malawi? A protocol for a cluster randomised controlled trial. BMJ Open. 2024 Jan 1;14(1):e077706.
  98. Uhrig Castonguay BJ, LeMasters K, Corsi C, Batty EJ, Krajewski TJ, Travis M, Waleed C, Oser CB, Nowotny KM, Brinkley-Rubinstein L. Retention strategies among those on community supervision in the South: Lessons learned during the COVID-19 pandemic. Plos one. 2023 Apr 5;18(4):e0283621.
  99. Vias, N.P., Cassidy, C.E., Edwards, J.K., Xiong, K., Parker, C.B., Aiello, A.E., Boyce, R.M., Shook-Sa, B.E., 2023 “Accounting for outcome misclassification in complex sample designs: estimation of SARS-CoV-2 seroprevalence in central North Carolina.” Epidemiology, 34(5): 721-731. PMC10403265
  100. Vijayan KV, Cross KA, Curtis AD, Van Rompay KK, Pollara J, Fox CB, Tomai M, Hanke T, Fouda G, Hudgens MG, Permar SR. Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques. Frontiers in Immunology. 2022 Apr 27;13:840976.
  101. Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH, Liu H, Madden VJ, Krzystek HM, De C, White KK et al. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. 2021 Mar;591(7850):451-7. PMC7979515
  102. Wahl A, Yao W, Liao B, Chateau M, Richardson C, Ling L, Franks A, Senthil K, Doyon G, Li F, Frost J et al. A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection. Nature Biotechnology. 2024 Jun;42(6):905-15.
  103. Wang C, Ong JJ, Zhao P, Weideman AM, Tang W, Smith MK, Marks M, Fu H, Cheng W, Terris-Prestholt F, Zheng H, Tucker JD, Yang B. Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial. PLoS Med. 2022 Mar 2;19(3):e1003930. doi: 10.1371/journal.pmed.1003930. PMID: 35235573; PMCID: PMC8890628.
  104. Wang C, Zhao P, Weideman AM, Xu W, Ong JJ, Jamil MS, Yang B, Tucker JD, 2023. “Expanding hepatitis C virus test uptake using self-testing among men who have sex with men in China: two parallel randomized controlled trials.” BMC Med, 21(1): 279. PMC10386771
  105. Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan N, Adimora AA, Archin N. CD8 T Cell Virus Inhibition Assay Protocol. Bio-protocol. 2022 Mar 20;12(6):e4354-.
  106. Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan NR, Adimora AA, Archin N. Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication. Frontiers in immunology. 2021 Jun 30;12:666991.
  107. Yin DE, Cole SR, Ludema C, Brookhart MA, Golin CE, Miller WC, McKinney RE, 2023. “A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children.” American Journal of Epidemiology, 192(6):916-928. PMC10505414
  108. Zalla LC, Cole SR, Eron JJ, Adimora AA, Vines AI, Althoff KN, Silverberg MJ, Horberg MA, Marconi VC, Coburn SB, Lang R. Association of race and ethnicity with initial prescription of antiretroviral therapy among people with HIV in the US. JAMA. 2023 Jan 3;329(1):52-62.
  109. Zalla LC, Cole SR, Eron JJ, Adimora AA, Vines AI, Althoff KN, Marconi VC, Gill MJ, Horberg MA, Silverberg MJ, Rebeiro PF. Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality Among People With Human Immunodeficiency Virus in the United States. The Journal of Infectious Diseases. 2023 Dec 15;228(12):1690-8.
  110. Zalla, L.C., Edwards, J.K., Cole, S.R., Rudolph, J.E., Breger, T.L., Virkud, A., Johnson, A.S. and Hall, H.I., 2021. Demographic Trends in US HIV Diagnoses, 2008-2017: Data Movies. American Journal of Public Health, 111(4), pp.529-532. PMC7958054
  111. Zeziulin O, Mollan KR, Shook-Sa BE, Hanscom B, Lancaster KE, Dumchev K, Go VF, Chu VA, Kiriazova T, Syarif Z, Dvoryaka S. Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs. AIDS. 2021 35(3), pp.495-501. PMC7855840
  112. Zhou, S, CS Hill, E Spielvogel, MU Clark, MG Hudgens, R Swanstrom. “Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA Viruses.” ACS Infectious Diseases 2022, 8(12): 2505-2514. PMC9742341
  113. Zhou Y, Lu Y, Ni Y, Wu D, He X, Ong JJ, Tucker JD, Sylvia SY, Jing F, Li X, Huang S, Shen G, Xu C, Xiong Y, Sha Y, Cheng M, Xu J, Jiang H, Dai W, Huang L, Zou F, Wang C, Yang B, Mei W, Tang W. Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial. PLoS Med. 2022 Feb 14;19(2):e1003928. PMCID: PMC8887971
  114. Zivich PN, Cole SR, Edwards JK, Mulholland GE, Shook-Sa BE, Tchetgen Tchetgen E, 2023. “Introducing Proximal Causal Inference for Epidemiologists.” American Journal of Epidemiology, 192(7): 1224–1227. PMC10505426
  115. Zivich PN, Cole SR, Edwards JK, Glidden DV, Das M, Shook-Sa BE, Shao Y, Mehrotra ML, Adimora AA, Eron JJ. HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo. The Journal of Infectious Diseases. 2024 Apr 15;229(4):1123-30.
  116. Zivich PN, Cole SR, Edwards JK, Mulholland GE, Shook-Sa BE, Tchetgen Tchetgen EJ. Introducing proximal causal inference for epidemiologists. American Journal of Epidemiology. 2023 Jul;192(7):1224-7. PMC10505426.
  117. Zivich PN, Cole SR, Hudgens MG, Edwards JK, Shook-Sa BE, Breskin A. “Bridged treatment comparisons: an illustrative application in HIV treatment.” American Journal of Epidemiology. In Press. PMID: 39218437
  118. Zivich PN, Edwards JK, Shook-Sa BE, Lofgren ET, Lessler J, Cole SR. Synthesis estimators for transportability with positivity violations by a continuous covariate. Journal of the Royal Statistical Society Series A: Statistics in Society. 2024. In press.
  119. Zivich PN, Shook-Sa BE. Estimating marginal structural model parameters for time-fixed, binary actions with g-computation and estimating equations. American Journal of Epidemiology. 2024. In press. PMID: 39191643

 

Boyce RM, Ndizeye R, Ngelese H, Baguma E, Shem B, Rubinstein RJ, Rockwell E, Lotspeich SC, Shook-Sa BE, Ntaro M, Nyehangane D, Wohl DA, Siedner MJ, Mulogo EM. It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda. PLOS Glob Public Health. 2023 Mar 27;3(3):e0001678. PMID: 36972208; PMCID: PMC10042348.

Cole SR, Edwards JK, Breskin A, Rosin S, Zivich PN, Shook-Sa BE, Hudgens MG. Illustration of 2 Fusion Designs and Estimators. Am J Epidemiol. 2023 Feb 24;192(3):467-474. PMID: 35388406.

Cole SR, Zivich PN, Edwards JK, Shook-Sa BE, Hudgens MG. Sensitivity Analyses for Means or Proportions with Missing Outcome Data. Epidemiology. 2023 May 9.  PMID: 37155639.

Cole SR, Zivich PN, Edwards JK, Ross RK, Shook-Sa BE, Price JT, Stringer JSA. Missing Outcome Data in Epidemiologic Studies. Am J Epidemiol. 2023 Jan 6;192(1):6-10. PMID: 36222655; PMCID: PMC10144620.

DeMonte J, McCumber M, Slye N, Amico KR, Arnold EM, Comulada WS, Hayati Rezvan P, Hightow-Weidman LB, Muessig KE, Nichols SL, Nielsen-Saines K, Sanchez TH, Shook-Sa BE, Swendeman D, Valencia RK, Hudgens MG. Adolescents Living With or at Risk for HIV: A Pooled Descriptive Analysis of Studies From the Adolescent Medicine Trials Network for HIV/AIDS Interventions. J Adolesc Health. 2023 May;72(5):712-721. PMID: 36803999; PMCID: PMC10121857.

Edwards JK, Cole SR, Shook-Sa BE, Zivich PN, Zhang N, Lesko CR. When Does Differential Outcome Misclassification Matter for Estimating Prevalence? Epidemiology. 2023 Mar 1;34(2):192-200. PMID: 36722801; PMCID: PMC10237297.

Harper GW, Cherenack EM, Slye N, Jadwin-Cakmak L, Hudgens M. Pilot Trial of a Critical Consciousness-Based Intervention for Black Young Gay and Bisexual Men Living with HIV: Mobilizing Our Voices for Empowerment (MOVE). J Racial Ethn Health Disparities. 2023 Feb;10(1):64-82. PMID: 35048310; PMCID: PMC9296697.

Jetsupphasuk M, Hudgens MG, Lu H, Cole SR, Edwards JK, Adimora AA, Althoff KN, Silverberg MJ, Rebeiro PF, Lima VD, Marconi VC, Sterling TR, Horberg MA, Gill MJ, Kitahata MM, Moore RD, Lang R, Gebo K, Rabkin C, Eron JJ. Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. Am J Epidemiol. 2023 Mar 15:kwad057. PMID: 36922393.

LeMasters K, Benson A, Corsi C, Krajewski T, Seide K, Brinkley-Rubinstein L, Nowotny K. Collateral consequences of COVID-19 for people on probation and parole. Health Justice. 2023 Mar 30;11(1):18. PMID: 36995422; PMCID: PMC10060932.

LeMasters K, Krajewski T, Nowotny K, Oser C, Mollan K, Brinkley-Rubinstein L. Context specific HIV risk: evidence from screening into the southern pre-exposure prophylaxis study (SPECS). AIDS Care. 2023 Apr;35(4):474-479. PMID: 35377251; PMCID: PMC9530063.

Lindsey JC, Hudgens M, Gaur AH, Horvath KJ, Dallas R, Heckman B, Mueller Johnson M, Amico KR. Electronic Dose Monitoring Device Patterns in Youth Living With HIV Enrolled in an Adherence Intervention Clinical Trial. J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):231-241. PMID: 36730762; PMCID: PMC9928806.

Milligan EC, Olstad K, Williams CA, Mallory M, Cano P, Cross KA, Munt JE, Garrido C, Lindesmith L, Watanabe J, Usachenko JL, Hopkins L, Immareddy R, Shaan Lakshmanappa Y, Elizaldi SR, Roh JW, Sammak RL, Pollard RE, Yee JL, Herbek S, Scobey T, Miehlke D, Fouda G, Ferrari G, Gao H, Shen X, Kozlowski PA, Montefiori D, Hudgens MG, Edwards DK, Carfi A, Corbett KS, Graham BS, Fox CB, Tomai M, Iyer SS, Baric R, Reader R, Dittmer DP, Van Rompay KKA, Permar SR, De Paris K. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later. Sci Transl Med. 2023 Mar;15(685):eadd6383. PMID: 36454813; PMCID: PMC9765459.

Rosenberg NE, Shook-Sa BE, Liu M, Stranix-Chibanda L, Yotebieng M, Sam-Agudu NA, Hudgens MG, Phiri SJ, Mutale W, Bekker LG, Moyo S, Zuma K, Charurat ME, Justman J, Chi BH. Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. Lancet HIV. 2023 Mar;10(3):e175-e185. PMID: 36702151; PMCID: PMC10126805.

Sadinski LM, Westreich D, Edmonds A, Breger TL, Cole SR, Ramirez C, Brown TT, Ofotokun I, Konkle-Parker D, Kassaye S, Jones DL, D’Souza G, Cohen MH, Tien PC, Taylor TN, Anastos K, Adimora AA. Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States. AIDS. 2023 Mar 15;37(4):679-688. PMID: 36728933; PMCID: PMC9974900.

Sanusi B, Cai J, Hudgens MG. Nonparametric estimation of marked survival data in the presence of dependent censoring. Stat Med. 2023 May 30;42(12):1995-2008. PMID: 36945185; PMCID: PMC10192031.

Vias, N.P., Cassidy, C.E., Edwards, J.K., Xiong, K., Parker, C.B., Aiello, A.E., Boyce, R.M., Shook-Sa, B.E.“Accounting for outcome misclassification in complex sample designs: estimation of SARS-CoV-2 seroprevalence in central North Carolina.” Epidemiology, In press.

Zalla LC, Cole SR, Eron JJ, Adimora AA, Vines AI, Althoff KN, Silverberg MJ, Horberg MA, Marconi VC, Coburn SB, Lang R, Williams EC, Gill MJ, Gebo KA, Klein M, Sterling TR, Rebeiro PF, Mayor AM, Moore RD, Edwards JK. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 Jan 3;329(1):52-62. PMID: 36594946; PMCID: PMC9856806.

Zivich PN, Cole SR, Edwards JK, Mulholland GE, Shook-Sa BE, Tchetgen Tchetgen EJ. Introducing Proximal Causal Inference for Epidemiologists. Am J Epidemiol. 2023 Mar 31:kwad077. PMID: 37005072.

Boyce RM, Muhindo E, Baguma E, Muhindo R, Shem B, François R, Hawke S, Shook-Sa BE, Ntaro M, Nalusaji A, Nyehangane D, Reyes R, Juliano JJ, Siedner MJ, Staedke SG, Mulogo EM. Permethrin-treated baby wraps for the prevention of malaria: results of a randomized controlled pilot study in rural Uganda. Malar J. 2022 Feb 23;21(1):63. PMID: 35197060; PMCID: PMC8864600.

Breger TL, Westreich D, Edmonds A, Edwards JK, Zalla LC, Cole SR, Ramirez C, Ofotokun I, Kassaye SG, Brown TT, Konkle-Parker D, Jones DL, D’Souza G, Cohen MH, Tien PC, Taylor TN, Anastos K, Adimora AA. A new smoking cessation ‘cascade’ among women with or at risk for HIV infection. AIDS. 2022 Jan 1;36(1):107-116. PMID: 34586086; PMCID: PMC8819357.

Cerami C, Popkin-Hall ZR, Rapp T, Tompkins K, Zhang H, Muller MS, Basham C, Whittelsey M, Chhetri SB, Smith J, Litel C, Lin KD, Churiwal M, Khan S, Rubinstein R, Claman F, Mollan K, Wohl D, Premkumar L, Powers KA, Juliano JJ, Lin FC, Lin JT. Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of Color. Clin Infect Dis. 2022 May 30;74(10):1776-1785. PMID: 34383889; PMCID: PMC8436395.

Chibwesha CJ, Mollan KR, Ford CE, Shibemba A, Saha PT, Lusaka M, Mbewe F, Allmon AG, Lungu R, Spiegel HML, Mweni E, Mwape H, Kankasa C, Chi BH, Stringer JSA. A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia. Clin Infect Dis. 2022 Aug 25;75(2):260-268. PMID: 34718462; PMCID: PMC9410723.

Clutton GT, Weideman AMK, Goonetilleke NP, Maurer T. An expanded population of CD8dim T cells with features of mitochondrial dysfunction and senescence is associated with persistent HIV-associated Kaposi’s sarcoma under ART. Front Cell Dev Biol. 2022 Sep 29;10:961021. PMID: 36247006; PMCID: PMC9557199.

Conner MG, Vwalika B, Freeman BL, Sebastião YV, Mabula-Bwalya CM, Cole SR, Stringer EM, Kasaro MP, Stringer JSA, Price JT. Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia. AIDS. 2022 Nov 15;36(14):2079-2081. PMID: 36305188; PMCID: PMC9624437.

Curtis AD 2nd, Saha PT, Dennis M, Berendam SJ, Ramasubramanian P, Cross KA, Alam SM, Ferrari G, Kozlowski PA, Fouda GG, Hudgens MG, Van Rompay KKA, Pollara J, Permar SR, De Paris K. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection. mSphere. 2022 Feb 23;7(1):e0083921. PMID: 35196125; PMCID: PMC8865927.

Edwards JK, Cole SR, Breger TL, Filiatreau LM, Zalla L, Mulholland GE, Horberg MA, Silverberg MJ, John Gill M, Rebeiro PF, Thorne JE, Kasaie P, Marconi VC, Sterling TR, Althoff KN, Moore RD, Eron JJ. Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population. Clin Infect Dis. 2022 Sep 14;75(5):867-874. PMID: 34983066; PMCID: PMC9477443.

Fischer WA 2nd, Eron JJ Jr, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Coombs RW, James Loftis A, Alabanza P, Lipansky F, Painter WP. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci Transl Med. 2022 Jan 19;14(628):eabl7430. PMID: 34941423.

Ha TV, Hoffman IF, Miller WC, Mollan KR, Lancaster KE, Richardson P, Zeziulin O, Djoerban Z, Sripaipan T, Chu VA, Guo X, Hanscom B, Go VF. Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074. J Subst Use. 2022;27(6):648-657.  PMID: 36742268; PMCID: PMC9897261.

Knittel AK, Rudolph JE, Shook-Sa BE, Edmonds A, Ramirez C, Cohen M, Taylor T, Adedimeji A, Michel KG, Milam J, Cohen J, Donohue JD, Foster A, Fischl MA, Long DM, Adimora AA. Self-Reported Sexually Transmitted Infections After Incarceration in Women with or at Risk for HIV in the United States, 2007-2017. J Womens Health (Larchmt). 2022 Mar;31(3):382-390. PMID: 34967695; PMCID: PMC8972014.

Li F, Buchanan AL, Cole SR. Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials. J R Stat Soc Ser C Appl Stat. 2022 Jun;71(3):669-697. PMID: 35968541; PMCID: PMC9367209.

Li L, Lee C, Cruz DF, Krovi SA, Hudgens MG, Cottrell ML, Johnson LM. Reservoir-Style Polymeric Drug Delivery Systems: Empirical and Predictive Models for Implant Design. Pharmaceuticals (Basel). 2022 Oct 3;15(10):1226. PMID: 36297338; PMCID: PMC9610229.

Li X, May S, Trumble IM, Archin NM, Hudgens MG. Paired serial limiting dilution assays. Stat Med. 2022 Oct 30;41(24):4809-4821. PMID: 35975729; PMCID: PMC9588648.

Lu H, Cole SR, Westreich D, Hudgens MG, Adimora AA, Althoff KN, Silverberg MJ, Buchacz K, Li J, Edwards JK, Rebeiro PF, Lima VD, Marconi VC, Sterling TR, Horberg MA, Gill MJ, Kitahata MM, Eron JJ, Moore RD; North American AIDS Cohort Collaboration on Research, Design of the International Epidemiologic Databases to Evaluate AIDS. Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy. AIDS. 2022 Feb 1;36(2):277-286. PMID: 34934020; PMCID: PMC9048218.

McNeil CJ, Lee JS, Cole SR, Patel SA, Martin J, Mathews WC, Moore RD, Mayer KH, Eron JJ, Saag MS, Kitahata MM, Achenbach CJ; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS). Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk? AIDS. 2022 Apr 1;36(5):657-664. PMID: 34923519; PMCID: PMC10115425.

Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL, Loftis AJ, Degli-Angeli EJ, Brown AJ, Dragavon JA, Won JJ, Keys J, Hudgens MG, Fang L, Wohl DA, Cohen MS, Baric RS, Coombs RW, Sheahan TP, Fischer WA. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates. Clin Infect Dis. 2022 Aug 24;75(1):e1028-e1036. PMID: 35022711; PMCID: PMC9402664.

Nelson AN, Dennis M, Mangold JF, Li K, Saha PT, Cronin K, Cross KA, Kumar A, Mangan RJ, Shaw GM, Bar KJ, Haynes B, Moody AM, Munir Alam S, Pollara J, Hudgens MG, Van Rompay KKA, De Paris K, Permar SR. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1. NPJ Vaccines. 2022 Jul 30;7(1):87. PMID: 35907918; PMCID: PMC9338948.

Pokaprakarn T, Prieto JC, Price JT, Kasaro MP, Sindano N, Shah HR, Peterson M, Akapelwa MM, Kapilya FM, Sebastião YV, Goodnight W 3rd, Stringer EM, Freeman BL, Montoya LM, Chi BH, Rouse DJ, Cole SR, Vwalika B, Kosorok MR, Stringer JSA. AI Estimation of Gestational Age from Blind Ultrasound Sweeps in Low-Resource Settings. NEJM Evid. 2022 May;1(5):10.1056/evidoa2100058. PMID: 36875289; PMCID: PMC9980216.

Price JT, Sebastião YV, Vwalika B, Cole SR, Mbewe FM, Phiri WM, Freeman BL, Kasaro MP, Peterson M, Rouse DJ, Stringer EM, Stringer JSA. Risk of Adverse Birth Outcomes in Two Cohorts of Pregnant Women With HIV in Zambia. Epidemiology. 2022 May 1;33(3):422-430. PMID: 35067569; PMCID: PMC9516482.

Rosenberg NE, Tembo TA, Simon KR, Mollan K, Rutstein SE, Mwapasa V, Masiano S, Huffstetler HE, Go V, Kim MH. Development of a Blended Learning Approach to Delivering HIV-Assisted Contact Tracing in Malawi: Applied Theory and Formative Research. JMIR Form Res. 2022 Apr 19;6(4):e32899. PMID: 35438644; PMCID: PMC9066333.

Shook-Sa BE, Hudgens MG, Kavee AL, Rosen DL. Estimating the Number of Persons with HIV in Jails via Web Scraping and Record Linkage. J R Stat Soc Ser A Stat Soc. 2022 Dec;185(Suppl 2):S270-S287. PMID: 36860267; PMCID: PMC9970294.

Vijayan KKV, Cross KA, Curtis AD 2nd, Van Rompay KKA, Pollara J, Fox CB, Tomai M, Hanke T, Fouda G, Hudgens MG, Permar SR, De Paris K. Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques. Front Immunol. 2022 Apr 27;13:840976. PMID: 35572573; PMCID: PMC9094446.

Wang C, Ong JJ, Zhao P, Weideman AM, Tang W, Smith MK, Marks M, Fu H, Cheng W, Terris-Prestholt F, Zheng H, Tucker JD, Yang B. Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial. PLoS Med. 2022 Mar 2;19(3):e1003930. Erratum in: PLoS Med. 2022 Aug 4;19(8):e1004071. PMID: 35235573; PMCID: PMC8890628.

Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan N, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG, Goonetilleke N. CD8 T Cell Virus Inhibition Assay Protocol. Bio Protoc. 2022 Mar 20;12(6):e4354. PMID: 35434196; PMCID: PMC8983397.

Zhou S, Hill CS, Spielvogel E, Clark MU, Hudgens MG, Swanstrom R. Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA Viruses. ACS Infect Dis. 2022 Dec 9;8(12):2505-2514. PMID: 36326446; PMCID: PMC9742341.

Zhou Y, Lu Y, Ni Y, Wu D, He X, Ong JJ, Tucker JD, Sylvia SY, Jing F, Li X, Huang S, Shen G, Xu C, Xiong Y, Sha Y, Cheng M, Xu J, Jiang H, Dai W, Huang L, Zou F, Wang C, Yang B, Mei W, Tang W. Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial. PLoS Med. 2022 Feb 14;19(2):e1003928. PMID: 35157727; PMCID: PMC8887971.

Boyce RM, Shook-Sa BE, Aiello AE. A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence. Clin Infect Dis. 2021 Nov 2;73(9):e3124-e3126. PMID: 33338219; PMCID: PMC7799336.

Breskin A, Cole SR, Edwards JK, Brookmeyer R, Eron JJ, Adimora AA. Fusion designs and estimators for treatment effects. Stat Med. 2021 Jun 15;40(13):3124-3137. Erratum in: Stat Med. 2023 Feb 28;42(5):730. PMID: 33783011; PMCID: PMC8237350.

Breskin A, Edmonds A, Cole SR, Westreich D, Cocohoba J, Cohen MH, Kassaye SG, Metsch LR, Sharma A, Williams MS, Adimora AA. G-computation for policy-relevant effects of interventions on time-to-event outcomes. Int J Epidemiol. 2021 Jan 23;49(6):2021-2029. Erratum in: Int J Epidemiol. 2021 May 17;50(2):701. PMID: 33141177; PMCID: PMC7825964.

Ceriani C, Streeter GS, Lemu KJ, James KS, Ghofrani S, Allard B, Shook-Sa BE, Margolis DM, Archin NM. Defining stable reference genes in HIV latency reversal experiments. J Virol. 2021 May 10;95(11):e02305-20. PMID: 33762410; PMCID: PMC8139712.

Cole SR, Edwards JK, Breskin A, Hudgens MG. Comparing Parametric, Nonparametric, and Semiparametric Estimators: The Weibull Trials. Am J Epidemiol. 2021 Aug 1;190(8):1643-1651. PMID: 33569578; PMCID: PMC8484780.

Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, Van Duin D, Wohl DA, Gebo KA, Moore RD, Althoff KN, Poteat T, Gill MJ, Horberg MA, Silverberg MJ, Nanditha NGA, Thorne JE, Berry SA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. AIDS. 2021 Jul 1;35(8):1229-1239. PMID: 33710020; PMCID: PMC8172437.

Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, van Duin D, Wohl DA, Hogan BC, Althoff KN, Gebo KA, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Mathews WC, Klein MB, Colasanti JA, Sterling TR, Mayor AM, Rebeiro PF, Buchacz K, Li J, Nanditha NGA, Thorne JE, Nijhawan A, Berry SA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA). Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. J Infect Dis. 2021 Aug 16;224(4):657-666. PMID: 34398239; PMCID: PMC8366443.

Diepstra KL, Barr L, Palm D, Hogg E, Mollan KR, Henley L, Stover AM, Simoni JM, Sugarman J, Brown B, Sauceda JA, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ, Dubé K. Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 2021 Jun;37(6):489-501. PMID: 33472545; PMCID: PMC8213012.

Edmonds A, Breskin A, Cole SR, Westreich D, Ramirez C, Cocohoba J, Wingood G, Cohen MH, Golub ET, Kassaye SG, Metsch LR, Sharma A, Konkle-Parker D, Wilson TE, Adimora AA. Poverty, Deprivation, and Mortality Risk Among Women With HIV in the United States. Epidemiology. 2021 Nov 1;32(6):877-885. PMID: 34347686; PMCID: PMC8478815.

Edwards JK, Cole SR, Breger TL, Rudolph JE, Filiatreau LM, Buchacz K, Humes E, Rebeiro PF, D’Souza G, Gill MJ, Silverberg MJ, Mathews WC, Horberg MA, Thorne J, Hall HI, Justice A, Marconi VC, Lima VD, Bosch RJ, Sterling TR, Althoff KN, Moore RD, Saag M, Eron JJ. Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study. Ann Intern Med. 2021 Sep;174(9):1197-1206. PMID: 34224262; PMCID: PMC8453103.

Falcinelli SD, Kilpatrick KW, Read J, Murtagh R, Allard B, Ghofrani S, Kirchherr J, James KS, Stuelke E, Baker C, Kuruc JD, Eron JJ, Hudgens MG, Gay CL, Margolis DM, Archin NM. Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy. J Infect Dis. 2021 Jul 2;224(1):92-100. PMID: 33216132; PMCID: PMC8253129.

Garrido C, Curtis AD 2nd, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE, Mallory ML, Saha PT, Hudgens MG, Lindesmith LC, Baric RS, Abiona OM, Graham B, Corbett KS, Edwards D, Carfi A, Fouda G, Van Rompay KKA, De Paris K, Permar SR. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci Immunol. 2021 Jun 15;6(60):eabj3684. PMID: 34131024; PMCID: PMC8774290.

Knittel AK, Shook-Sa BE, Rudolph JE, Edmonds A, Ramirez C, Cohen MH, Adedimeji A, Taylor TN, Michel KG, Milam J, Cohen J, Donohue JD, Foster A, Fischl M, Konkle-Parker D, Adimora AA. Incidence and Prevalence of Incarceration in a Longitudinal Cohort of Women at Risk for Human Immunodeficiency Virus in the United States, 2007-2017. J Womens Health (Larchmt). 2021 May;30(5):694-704. PMID: 33544023; PMCID: PMC8112715.

Lancaster KE, Mollan KR, Hanscom BS, Shook-Sa BE, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Go VF, Dvoriak S, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Nhan DT, Burns DN, Miller WC, Hoffman IF. Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074. Open Forum Infect Dis. 2021 May 29;8(8):ofab281. PMID: 34458390; PMCID: PMC8391093.

LeMasters K, Oser C, Cowell M, Mollan K, Nowotny K, Brinkley-Rubinstein L. Longitudinal pre-exposure prophylaxis (PrEP) acceptability, initiation and adherence among criminal justice-involved adults in the USA: the Southern PrEP Cohort Study (SPECS) protocol. BMJ Open. 2021 Jul 16;11(7):e047340. PMID: 34272219; PMCID: PMC8287623.

Lin JT, Mollan KR, Cerami C. The Consequences of Isolating at Home. Clin Infect Dis. 2021 Nov 2;73(9):e2823. PMID: 32986803.

Lu H, Cole SR, Westreich D, Hudgens MG, Adimora AA, Althoff KN, Silverberg MJ, Buchacz K, Li J, Edwards JK, Rebeiro PF, Lima VD, Marconi VC, Sterling TR, Horberg MA, Gill MJ, Kitahata MM, Eron JJ, Moore RD. Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada. Clin Infect Dis. 2021 Oct 5;73(7):e1408-e1414. Erratum in: Clin Infect Dis. 2022 Mar 1;74(4):755. PMID: 32780095; PMCID: PMC8492356.

Mollan KR, Pence BW, Xu S, Edwards JK, Mathews WC, O’Cleirigh C, Crane HM, Eaton EF, Collier AC, Weideman AMK, Westreich D, Cole SR, Tierney C, Bengtson AM; CFAR Network of Integrated Clinical Systems and the AIDS Clinical Trials Group. Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or Behaviors. Am J Epidemiol. 2021 Oct 1;190(10):2075-2084. PMID: 33972995; PMCID: PMC8576379.

Mutale W, Freeborn K, Graybill LA, Lusaka MM, Mollan KR, Mweemba O, Kasaro M, Lungu R, Kumwenda A, Saidi F, Powers KA, Maman S, Rosenberg NE, Chi BH. Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials. Lancet Glob Health. 2021 Dec;9(12):e1719-e1729. PMID: 34735862; PMCID: PMC8644317.

Price JT, Vwalika B, Edwards JK, Cole SR, Kasaro MP, Rittenhouse KJ, Kumwenda A, Lubeya MK, Stringer JSA. Maternal HIV Infection and Spontaneous Versus Provider-Initiated Preterm Birth in an Urban Zambian Cohort. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):860-868. PMID: 33587508; PMCID: PMC8131221.

Price JT, Vwalika B, Freeman BL, Cole SR, Saha PT, Mbewe FM, Phiri WM, Peterson M, Muyangwa D, Sindano N, Mwape H, Smithmyer ME, Kasaro MP, Rouse DJ, Goldenberg RL, Chomba E, Stringer JSA. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2021 Oct;8(10):e605-e613. PMID: 34509197; PMCID: PMC8476342.

Smith JS, Backes DM, Hudgens MG, Mei W, Chakraborty H, Rohner E, Moses S, Agot K, Meijer CJLM, Bailey RC. Male Circumcision Reduces Penile HPV Incidence and Persistence: A Randomized Controlled Trial in Kenya. Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1139-1148. PMID: 33972367; PMCID: PMC8172477.

Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH 3rd, Liu H, Madden VJ, Krzystek HM, De C, White KK, Gully K, Schäfer A, Zaman T, Leist SR, Grant PO, Bluemling GR, Kolykhalov AA, Natchus MG, Askin FB, Painter G, Browne EP, Jones CD, Pickles RJ, Baric RS, Garcia JV. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. 2021 Mar;591(7850):451-457. PMID: 33561864; PMCID: PMC7979515.

Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan NR, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG, Goonetilleke N. Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication. Front Immunol. 2021 Jun 30;12:666991. Erratum in: Front Immunol. 2023 Jan 03;13:1104661. PMID: 34276657; PMCID: PMC8278574.

Zalla LC, Edwards JK, Cole SR, Rudolph JE, Breger TL, Virkud A, Johnson AS, Hall HI. Demographic Trends in US HIV Diagnoses, 2008-2017: Data Movies. Am J Public Health. 2021 Apr;111(4):529-532. PMID: 33689438; PMCID: PMC7958054.

Zeziulin O, Mollan KR, Shook-Sa BE, Hanscom B, Lancaster KE, Dumchev K, Go VF, Chu VA, Kiriazova T, Syarif Z, Dvoryak S, Reifeis SA, Hamilton E, Sarasvita R, Rose S, Richardson P, Clarke W, Latkin CA, Metzger DS, Hoffman IF, Miller WC. Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs. AIDS. 2021 Mar 1;35(3):495-501. PMID: 33252489; PMCID: PMC7855840.

Barzin A, Schmitz JL, Rosin S, Sirpal R, Almond M, Robinette C, Wells S, Hudgens M, Olshan A, Deen S, Krejci P, Quackenbush E, Chronowski K, Cornaby C, Goins J, Butler L, Aucoin J, Boyer K, Faulk J, Alston-Johnson D, Page C, Zhou Y, Fiscus L, Damania B, Dittmer DP, Peden DB. SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures. mBio. 2020 Sep 29;11(5):e02426-20. PMID: 32994333; PMCID: PMC7527736.

Benkeser D, Horvath K, Reback CJ, Rusow J, Hudgens M. Design and analysis considerations for a sequentially randomized HIV prevention trial. Stat Biosci. 2020 Dec;12(3):446-467. PMID: 33767798; PMCID: PMC7986973.

Breger TL, Edwards JK, Cole SR, Saag M, Rebeiro PF, Moore RD, Eron JJ. Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of Death. Epidemiology. 2020 Sep;31(5):704-712. PMID: 32541609; PMCID: PMC7822729.

Breger TL, Edwards JK, Cole SR, Westreich D, Pence BW, Adimora AA. Two-stage g-computation: Evaluating Treatment and Intervention Impacts in Observational Cohorts When Exposure Information Is Partly Missing. Epidemiology. 2020 Sep;31(5):695-703. PMID: 32657953; PMCID: PMC8725064.

Cope AB, Edmonds A, Ludema C, Cole SR, Eron JJ, Anastos K, Cocohoba J, Cohen M, Ofotokun I, Golub ET, Kassaye S, Konkle-Parker D, Metsch LR, Wilson TE, Adimora AA. Neighborhood Poverty and Control of HIV, Hypertension, and Diabetes in the Women’s Interagency HIV Study. AIDS Behav. 2020 Jul;24(7):2033-2044.  PMID: 31907676; PMCID: PMC7319872.

Curtis AD 2nd, Dennis M, Eudailey J, Walter KL, Cronin K, Alam SM, Choudhary N, Tuck RH, Hudgens M, Kozlowski PA, Pollara J, Ferrari G, Van Rompay KKA, Permar S, De Paris K. HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy. mSphere. 2020 Mar 25;5(2):e00162-20. PMID: 32213623; PMCID: PMC7096624.

Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, Vance DE, Adimora AA. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00177-20. PMID: 32631821; PMCID: PMC7449168.

Edwards JK, Cole SR, Fox MP. Flexibly Accounting for Exposure Misclassification With External Validation Data. Am J Epidemiol. 2020 Aug 1;189(8):850-860. PMID: 31971584; PMCID: PMC7608057.

Falcinelli SD, Shook-Sa BE, Dewey MG, Sridhar S, Read J, Kirchherr J, James KS, Allard B, Ghofrani S, Stuelke E, Baker C, Roan NR, Eron JJ, Kuruc JD, Ramirez C, Gay C, Mollan KR, Margolis DM, Adimora AA, Archin NM. Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy. J Infect Dis. 2020 Nov 9;222(11):1843-1852. PMID: 32496542; PMCID: PMC7653086.

Gay CL, Kuruc JD, Falcinelli SD, Warren JA, Reifeis SA, Kirchherr JL, James KS, Dewey MG, Helms A, Allard B, Stuelke E, Gamble A, Plachco A, Gorelick RJ, Eron JJ, Hudgens M, Garrido C, Goonetilleke N, DeBenedette MA, Tcherepanova IY, Nicolette CA, Archin NM, Margolis DM. Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection. Sci Rep. 2020 Mar 20;10(1):5134. PMID: 32198428; PMCID: PMC7083965.

Gilbert PB, Blette BS, Shepherd BE, Hudgens MG. Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial. J Causal Inference. 2020;8(1):54-69. PMID: 33777613; PMCID: PMC7996712.

Gilliland WM , White NR , Yam BH , Mwangi JN , Prince HMA , Weideman AM , Kashuba ADM , Rosen EP . Influence of hair treatments on detection of antiretrovirals by mass spectrometry imaging. Analyst. 2020 Jul 7;145(13):4540-4550. PMID: 32420552; PMCID: PMC8290328.

Graybill LA, Kasaro M, Freeborn K, Walker JS, Poole C, Powers KA, Mollan KR, Rosenberg NE, Vermund SH, Mutale W, Chi BH. Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2020 Apr 1;34(5):761-776. PMID: 32167990; PMCID: PMC7275092.

James KS, Trumble I, Clohosey ML, Moeser M, Roan NR, Adimora AA, Joseph SB, Archin NM, Hudgens M, Soriano-Sarabia N. Measuring the contribution of γδ T cells to the persistent HIV reservoir. AIDS. 2020 Mar 1;34(3):363-371. PMID: 31764074; PMCID: PMC6994336.

Knittel AK, Shook-Sa BE, Rudolph J, Edmonds A, Ramirez C, Cohen M, Adedimeji A, Taylor T, Michel KG, Milam J, Cohen J, Donohue J, Foster A, Fischl M, Konkle-Parker D, Adimora AA. Incarceration and Number of Sexual Partners After Incarceration Among Vulnerable US Women, 2007-2017. Am J Public Health. 2020 Jan;110(S1):S100-S108. PMID: 31967873; PMCID: PMC6987934.

Mollan KR, Trumble IM, Reifeis SA, Ferrer O, Bay CP, Baldoni PL, Hudgens MG. Precise and accurate power of the rank-sum test for a continuous outcome. J Biopharm Stat. 2020 Jul 3;30(4):639-648. PMID: 32126888; PMCID: PMC7316590.

Nelson JAE, De Paris K, Ramirez C, Edmonds A, Mollan KR, Bay CP, Compliment K, Herold BC, Anastos K, Minkoff H, Kassaye S, Seidman DL, French AL, Golub ET, Sheth AN, Ochsenbauer C, Swanstrom R, Eron JJ, Adimora AA. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma. AIDS. 2020 Jan 1;34(1):39-46. PMID: 31483374; PMCID: PMC6910230.

Pilcher CD, Westreich D, Hudgens MG. Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence. J Infect Dis. 2020 Aug 17;222(6):903-909. PMID: 32592581; PMCID: PMC7337777.

Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JAE, O’Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS. Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2651-2661. PMID: 32943435; PMCID: PMC7710587.

Yang F, Zhang TP, Tang W, Ong JJ, Alexander M, Forastiere L, Kumar N, Li KT, Zou F, Yang L, Mi G, Wang Y, Huang W, Lee A, Zhu W, Luo D, Vickerman P, Wu D, Yang B, Christakis NA, Tucker JD. Pay-it-forward gonorrhoea and chlamydia testing among men who have sex with men in China: a randomised controlled trial. Lancet Infect Dis. 2020 Aug;20(8):976-982. PMID: 32530426; PMCID: PMC8957706.